Subscriber Authentication Point
lvrea
Home All issues Volume 27 / No 5 (Septembre 2018) Méd. Intensive Réa., 27 5 (2018) 461-474 References
Free Access
Issue
Méd. Intensive Réa.
Volume 27, Number 5, Septembre 2018
Neuroréanimation et toxicologie
Page(s) 461 - 474
Section Article original / Original article
DOI https://doi.org/10.3166/rea-2018-0064
Published online 18 September 2018
  • George SMC, Harrison DA, Welch CA, Nolan KM, Friedmann PS, (2008) Dermatological conditions in intensive care: a secondary analysis of the Intensive Care National Audit and Research Centre (ICNARC) Case Mix Programme database. Crit Care Lond Engl 12: S1 [CrossRef] [Google Scholar]
  • Stevens DL, Bryant AE, (2017) Necrotizing soft-tissue infections. N Engl J Med 377: 2253–2265 [CrossRef] [PubMed] [Google Scholar]
  • Soltani AM, Best MJ, Francis CS, Allan BJ, Askari M, Panthaki ZJ, (2014) Trends in the incidence and treatment of necrotizing soft tissue infections: an analysis of the national hospital discharge survey. J Burn Care Res 35: 449–454 [PubMed] [Google Scholar]
  • Van Stigt SFL, de Vries J, Bijker JB, Mollen RMHG, Hekma EJ, Lemson SM, Tan ECTH, (2016) Review of 58 patients with necrotizing fasciitis in the Netherlands. World J Emerg Surg 11: 21 [CrossRef] [Google Scholar]
  • Nuwayhid ZB, Aronoff DM, Mulla ZD, (2007) Blunt trauma as a risk factor for group A streptococcal necrotizing fasciitis. Ann Epidemiol 17: 878–881 [CrossRef] [PubMed] [Google Scholar]
  • Nicot R, Hippy C, Hochart C, Wiss A, Brygo A, Gautier S, Caron J, Ferri J, Raoul G, (2013) Les anti-inflammatoires aggravent-ils les cellulites faciales d’origine dentaire ? Rev Stomatol Chir Maxillo-Fac Chir Orale 114: 304–309 [Google Scholar]
  • Weng TC, Chen CC, Toh HS, Tang HJ, (2011) Ibuprofen worsens Streptococcus pyogenes soft tissue infections in mice. J Microbiol Immunol Infect 44: 418–423 [CrossRef] [Google Scholar]
  • Brun-Buisson CJ, Saada M, Trunet P, Rapin M, Roujeau JC, Revuz J, (1985) Haemolytic streptococcal gangrene and nonsteroidal anti-inflammatory drugs. BMJ 290: 1786 [CrossRef] [Google Scholar]
  • Hua C, Sbidian E, Hemery F, Decousser JW, Bosc R, Amathieu R, Rahmouni A, Wolkenstein P, Valeyrie-Allanore L, Brun-Buisson C, de Prost N, Chosidow O, (2015) Prognostic factors in necrotizing soft-tissue infections (NSTI): a cohort study. J Am Acad Dermatol 73: 1006–1012.e8 [CrossRef] [PubMed] [Google Scholar]
  • Gelbard RB, Ferrada P, Yeh DD, Williams B, Loor M, Yon J, Mentzer C, Khwaja K, Khan M, Kohli A, Bulger EM, Robinson BRH, (2018) Optimal timing of initial debridement for necrotizing soft tissue infection: a practice management guideline from the Eastern Association for the Surgery of Trauma. J Trauma Acute Care Surg 85: 208–214. doi: 10.1097/TA.0000000000001857 [CrossRef] [PubMed] [Google Scholar]
  • Kiat HJ, En Natalie YH, Fatimah L, (2017) Necrotizing fasciitis: how reliable are the cutaneous signs? J Emerg Trauma Shock 10: 205–210 [CrossRef] [Google Scholar]
  • Kwak YG, Choi SH, Kim T, Park SY, Seo SH, Kim MB, Choi SH, (2017) Clinical guidelines for the antibiotic treatment for community-acquired skin and soft tissue infection. Infect Chemother 49: 301 [CrossRef] [PubMed] [Google Scholar]
  • Hietbrink F, Bode LG, Riddez L, Leenen LPH, van Dijk MR, (2016) Triple diagnostics for early detection of ambivalent necrotizing fasciitis. World J Emerg Surg 11: 51. eCollection 2016. doi: 10.1186/s13017-016-0108-z [CrossRef] [Google Scholar]
  • Gunaratne DA, Tseros EA, Hasan Z, Kudpaje AS, Suruliraj A, SmithMC, Riffat F, Palme CE, (2018) Cervical necrotizing fasciitis: systematic review and analysis of 1,235 reported cases from the literature. Head Neck. doi: 10.1002/hed.25184 [Epub ahead of print] [Google Scholar]
  • Wong CH, Khin LW, Heng KS, Tan KC, Low CO, (2004) The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections. Crit Care Med 32: 1535–1541 [CrossRef] [PubMed] [Google Scholar]
  • Neeki M, Dong F, Au C, Toy J, Khoshab N, Lee C, Kwong E, Yuen H, Lee J, Ayvazian A, Lux P, Borger R, (2017) Evaluating the laboratory risk indicator to differentiate cellulitis from necrotizing fasciitis in the emergency department. West J Emerg Med 18: 684–689 [CrossRef] [PubMed] [Google Scholar]
  • Simonart T, Nakafusa J, Narisawa Y, (2004) The importance of serum creatine phosphokinase level in the early diagnosis and microbiological evaluation of necrotizing fasciitis. J Eur Acad Dermatol Venereol 18: 687–690 [CrossRef] [PubMed] [Google Scholar]
  • Murphy G, Markeson D, Choa R, Armstrong A, (2013) Raised serum lactate: a marker of necrotizing fasciitis? J Plast Reconstr Aesthet Surg 66: 1712–1716 [CrossRef] [Google Scholar]
  • Rahmouni A, Chosidow O, Mathieu D, Gueorguieva E, Jazaerli N, Radier C, Faivre JM, Roujeau JC, Vasile N, (1994) MR imaging in acute infectious cellulitis. Radiology 192: 493–496 [CrossRef] [PubMed] [Google Scholar]
  • Kim KT, Kim YJ, Won Lee J, Kim YJ, Park SW, Lim MK, Suh CH, (2011) Can necrotizing infectious fasciitis be differentiated from nonnecrotizing infectious fasciitis with MR imaging? Radiology 259: 816–824 [CrossRef] [PubMed] [Google Scholar]
  • Goh T, Goh LG, Ang CH, Wong CH, (2014) Early diagnosis of necrotizing fasciitis: early diagnosis of necrotizing fasciitis. Br J Surg 101: e119–e125 [CrossRef] [PubMed] [Google Scholar]
  • Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJC, Gorbach SL, Hirschmann JV, Kaplan SL, Montoya JG, Wade JC, (2014) Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis 59: e10–e52 [CrossRef] [PubMed] [Google Scholar]
  • Elliott DC, Kufera JA, Myers RA, (1996) Necrotizing soft tissue infections. Risk factors for mortality and strategies for management. Ann Surg 224: 672–683 [CrossRef] [PubMed] [Google Scholar]
  • Saeed K, Esposito S, Gould I, Ascione T, Bassetti M, Bonnet E, Bouza E, ChanM, Davis JS, De Simone G, DrydenM, Gottlieb T, Hijazi K, Lye DC, Pagliano P, Petridou C, Righi E, Segreti J, Unal S, Yalcin AN, (2018) Hot topics in necrotising skin and soft tissue infections. Int J Antimicrob Agents. doi: 10.1016/j.ijantimicag.2018.02.012 [Epub 2018 Mar 6] [Google Scholar]
  • Brook I, Frazier EH, (1995) Clinical and microbiological features of necrotizing fasciitis. J Clin Microbiol 33: 2382–2387 [PubMed] [Google Scholar]
  • Henri Mondor Hospital Necrotizing Fasciitis Group; de Prost N, Sbidian E, Chosidow O, Brun-Buisson C, Amathieu R, (2015) Management of necrotizing soft tissue infections in the intensive care unit: results of an international survey. Intensive Care Med 41: 1506–1508 [CrossRef] [PubMed] [Google Scholar]
  • Holena DN, Mills AM, Carr BG, Wirtalla C, Sarani B, Kim PK, Braslow BM, Kelz RR, (2011) Transfer status: a risk factor for mortality in patients with necrotizing fasciitis. Surgery 150: 363–370 [CrossRef] [PubMed] [Google Scholar]
  • Burnham JP, Kirby JP, Kollef MH, (2016) Diagnosis and management of skin and soft tissue infections in the intensive care unit: a review. Intensive Care Med 42: 1899–1911 [CrossRef] [PubMed] [Google Scholar]
  • El-Menyar A, Asim M, Mudali IN, Mekkodathil A, Latifi R, Al-Thani H, (2017) The Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) scoring: the diagnostic and potential prognostic role. Scand J Trauma Resusc Emerg Med 25: 28. doi: 10.1186/s13049-017-0359-z [CrossRef] [PubMed] [Google Scholar]
  • Bernal NP, Latenser BA, Born JM, Liao J, (2012) Trends in 393 necrotizing acute soft tissue infection patients 2000–2008. Burns 38: 252–260 [CrossRef] [PubMed] [Google Scholar]
  • Audureau E, Hua C, de Prost N, Hemery F, Decousser JW, Bosc R, Lepeule R, Chosidow O, Sbidian E; the Henri Mondor Hospital Necrotizing Fasciitis Group, (2017) Mortality of necrotizing fasciitis: relative influence of individual and hospital-level factors, a nationwide multilevel study, France, 2007–12. Br J Dermatol 177: 1575–1582 [CrossRef] [PubMed] [Google Scholar]
  • Ingraham AM, Jung HS, Liepert AE, Warner-Hillard C, Greenberg CC, Scarborough JE, (2017) Effect of transfer status on outcomes for necrotizing soft tissue infections. J Surg Res 220: 372–378 [CrossRef] [PubMed] [Google Scholar]
  • Brengard-Bresler T, De Runz A, Bourhis F, Mezzine H, Khairallah G, Younes M, Brix M, Simon E, (2017) Postoperative quality of life of patients with a bacterial necrotizing dermis-hypodermitis or necrotizing fasciitis, a ten-year study. Ann Chir Plast Esthet 62: 31–44 [CrossRef] [PubMed] [Google Scholar]
  • SPILF; SFD, (2000) Conférence de consensus. Érysipèle et fasciite nécrosante : prise en charge. Med Mal Inf 30: 241–245 [Google Scholar]
  • Sriskandan S, McKee A, Hall L, Cohen J, (1997) Comparative effects of clindamycin and ampicillin on superantigenic activity of Streptococcus pyogenes. J Antimicrob Chemother 40: 275–277 [CrossRef] [PubMed] [Google Scholar]
  • Carapetis JR, Jacoby P, Carville K, Ang SJJ, Curtis N, Andrews R, (2014) Effectiveness of clindamycin and intravenous immunoglobulin, and risk of disease in contacts, in invasive group a streptococcal infections. Clin Infect Dis 59: 358–365 [CrossRef] [PubMed] [Google Scholar]
  • Darenberg J, Ihendyane N, Sjölin J, Aufwerber E, Haidl S, Follin P, Andersson J, Norrby-Teglund A; StreptIg Study Group, (2003) Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebocontrolled trial. Clin Infect Dis 37: 333–340 [CrossRef] [PubMed] [Google Scholar]
  • Linner A, Darenberg J, Sjolin J, Henriques-Normark B, Norrby-Teglund A, (2014) Clinical efficacy of polyspecific intravenous immunoglobulin therapy in patients with streptococcal toxic shock syndrome: a comparative observational study. Clin Infect Dis 59: 851–857 [CrossRef] [PubMed] [Google Scholar]
  • Kaul R, McGeer A, Norrby-Teglund A, Kotb M, Schwartz B, O’Rourke K, Talbot J, Low DE, (1999) Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome — a comparative observational study. Clin Infect Dis 28: 800–807 [CrossRef] [PubMed] [Google Scholar]
  • Kadri SS, Swihart BJ, Bonne SL, Hohmann SF, Hennessy LV, Louras P, Evans HL, Rhee C, Suffredini AF, Hooper DC, Follmann DA, Bulger EM, Danner RL, (2017) Impact of intravenous immunoglobulin on survival in necrotizing fasciitis with vasopressor-dependent shock: a propensity score-matched analysis from 130 US hospitals. Clin Infect Dis 64: 877–885 [PubMed] [Google Scholar]
  • Madsen MB, Hjortrup PB, Hansen MB, Lange T, Norrby-Teglund A, Hyldegaard O, Perner A, (2017) Immunoglobulin G for patients with necrotising soft tissue infection (INSTINCT): a randomised, blinded, placebo-controlled trial. Intensive Care Med 43: 1585–1593 [CrossRef] [PubMed] [Google Scholar]
  • Shaw JJ, Psoinos C, Emhoff TA, Shah SA, Santry HP, (2014) Not just full of hot air: hyperbaric oxygen therapy increases survival in cases of necrotizing soft tissue infections. Surg Infect 15: 328–335 [CrossRef] [Google Scholar]
  • Massey PR, Sakran JV, Mills AM, Sarani B, Aufhauser DD, Sims CA, Pascual JL, Kelz RR, Holena DN, (2012) Hyperbaric oxygen therapy in necrotizing soft tissue infections. J Surg Res 177: 146–151 [CrossRef] [PubMed] [Google Scholar]
  • Devaney B, Frawley G, Frawley L, Pilcher DV, (2015) Necrotising soft tissue infections: the effect of hyperbaric oxygen on mortality. Anaesth Intensive Care 43: 685–692 [PubMed] [Google Scholar]
  • Yang D, Davies A, Burge B, Watkins P, Dissanaike S, (2018) Open-to-air is a viable option for initial wound care in necrotizing soft tissue infection that allows early detection of recurrence without need for painful dressing changes or return to operating room. Surg Infect 19: 65–70 [CrossRef] [Google Scholar]
  • Ingen-Housz-Oro S, Duong TA, Bensaid B, Bellon N, de Prost N, Lu D, Lebrun-Vignes B, Gueudry J, Bequignon E, Zaghbib K, Royer G, Colin A, Do-Pham G, Bodemer C, Ortonne N, Barbaud A, Fardet L, Chosidow O,Wolkenstein P; French National Reference Center for Toxic Bullous Dermatoses, (2018) Epidermal necrolysis French national diagnosis and care protocol (PNDS; protocole national de diagnostic et de soins). Orphanet J Rare Dis 13: 56 [CrossRef] [PubMed] [Google Scholar]
  • Wang YH, Chen CB, Tassaneeyakul W, Saito Y, Aihara M, Choon SE, Lee HY, Chang MM, Roa FD, Wu CW, Zhang J, Nakkam N, Konyoung P, Okamoto-Uchida Y, Man-Tung Cheung C, Huang J, Ji C, Cheng B, Chung-Yee Hui R, Chu CY, Chen YJ, Wu CY, Hsu CK, Chiu TM, Ho HC, Lin JY, Yang CH, Chang YC, Su SC, Wang CW, Chung WH; for the Asian Severe Cutaneous Adverse Reaction Consortium, (2018) The medication risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in Asians: the major drug causality and comparison to the USA FDA Label. Clin Pharmacol Ther. doi: 10.1002/cpt.1071 [Epub ahead of print] [Google Scholar]
  • Duong TA, Valeyrie-Allanore L, Wolkenstein P, Chosidow O, (2017) Severe cutaneous adverse reactions to drugs. Lancet 390: 1996–2011 [CrossRef] [PubMed] [Google Scholar]
  • Bastuji-Garin S, Fouchard N, Bertocchi M, Roujeau JC, Revuz J, Wolkenstein P, (2000) SCORTEN: a severity-of-illness score for toxic epidermal necrolysis. J Invest Dermatol 115: 149–153 [CrossRef] [PubMed] [Google Scholar]
  • Ingen-Housz-Oro S, Duong TA, de Prost N, Colin A, Fardet L, Lebrun-Vignes B, Barbaud A, Chosidow O, Wolkenstein P; Centre de référence des dermatoses bulleuses toxiques et toxidermies graves et FISARD, (2018) Treatment of severe cutaneous adverse drug reactions. Ann Dermatol Venereol. doi: 10.1016/j. annder.2018.02.014 [Epub 2018 Apr 13] [Google Scholar]
  • Papo M, Valeyrie-Allanore L, Razazi K, Carteaux G, Wolkenstein P, Chosidow O, Brun-Buisson C, Mekontso Dessap A, de Prost N, (2017) Renal replacement therapy during Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective observational study of 238 patients. Br J Dermatol 176: 1370–1372 [CrossRef] [PubMed] [Google Scholar]
  • Wolkenstein P, Latarjet J, Roujeau JC, Duguet C, Boudeau S, Vaillant L, Maignan M, Schuhmacher MH, Milpied B, Pilorget A, Bocquet H, Brun-Buisson C, Revuz J, (1998) Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis. Lancet Lond Engl 352: 1586–1589 [CrossRef] [Google Scholar]
  • Wang CW, Yang LY, Chen CB, Ho HC, Hung SI, Yang CH, Chang CJ, Su SC, Hui RCY, Chin SW, Huang LF, Lin YYW, Chang WY, Fan WL, Yang CY, Ho JC, Chang YC, Lu CW, Chung WH, (2018) Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions. J Clin Invest 128: 985–996 [CrossRef] [PubMed] [Google Scholar]
  • Poizeau F, Gaudin O, Le Cleach L, Duong TA, Hua C, Hotz C, Ingen-Housz-Oro S, Sbidian E, Zehou O, Colin A, de Prost N, Lebrun-Vignes B, Chosidow O, Wolkenstein P, Fardet L, (2018) Cyclosporine for epidermal necrolysis: absence of beneficial effect in a retrospective cohort of 174 patients-exposed/unexposed and propensity score-matched analyses. J Invest Dermatol. doi: 10.1016/j.jid.2017.12.034 [Epub 2018 Jan 31] [Google Scholar]
  • Valeyrie-Allanore L, Wolkenstein P, Brochard L, Ortonne N, Maître B, Revuz J, Bagot M, Roujeau JC, (2010) Open trial of ciclosporin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis: Ciclosporin for SJS and TEN. Br J Dermatol 163: 847–853 [CrossRef] [PubMed] [Google Scholar]
  • Pinna A, Nuvoli E, Blasetti F, Posadinu MA, Boscia F, (2017) Plasmapheresis, intravenous immunoglobulins, and autologous serum eyedrops in the acute eye complications of toxic epidermal necrolysis. Eur J Ophthalmol 27: 658–663 [CrossRef] [PubMed] [Google Scholar]
  • De Prost N, Ingen-Housz-Oro S, Duong TA, Valeyrie-Allanore L, Legrand P, Wolkenstein P, Brochard L, Brun-Buisson C, Roujeau JC, (2010) Bacteremia in Stevens-Johnson syndrome and toxic epidermal necrolysis: epidemiology, risk factors, and predictive value of skin cultures. Medicine 89: 28–36 [CrossRef] [PubMed] [Google Scholar]
  • Tocco-Tussardi I, Huss F, Presman B, (2017) Microbiological findings and antibacterial therapy in Stevens-Johnson syndrome/toxic epidermal necrolysis patients from a Swedish Burn Center. J Cutan Pathol 44: 420–432 [CrossRef] [PubMed] [Google Scholar]
  • De Prost N, Mekontso-Dessap A, Valeyrie-Allanore L, Van Nhieu JT, Duong TA, Chosidow O, Wolkenstein P, Brun-Buisson C, Maître B, (2014) Acute respiratory failure in patients with toxic epidermal necrolysis: clinical features and factors associated with mechanical ventilation. Crit Care Med 42: 118–128 [CrossRef] [PubMed] [Google Scholar]
  • De Prost N, Mekontso-Dessap A, Valeyrie-Allanore L, Maître B, (2013) Atteintes bronchopulmonaires au cours des toxidermies graves. Reanimation 22: 73–79 [CrossRef] [Google Scholar]
  • Kimmoun A, Dubois E, Perez P, Barbaud A, Levy B, (2013) Shock state: an unrecognized and underestimated presentation of drug reaction with eosinophilia and systemic symptoms. Shock 40: 387–391 [CrossRef] [Google Scholar]
  • Eshki M, Allanore L, Musette P, Milpied B, Grange A, Guillaume JC, Chosidow O, Guillot I, Paradis V, Joly P, Crickx B, Ranger-Rogez S, Descamps V, (2009) Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: a cause of unpredictable multiorgan failure. Arch Dermatol 145: 67–72. doi: 10.1001/archderm.145.1.67 [CrossRef] [PubMed] [Google Scholar]
  • Cacoub P, Musette P, Descamps V, Meyer O, Speirs C, Finzi L, Roujeau JC, (2011) The DRESS syndrome: a literature review. Am J Med 124: 588–597 [CrossRef] [PubMed] [Google Scholar]
  • Funck-Brentano E, Duong TA, Bouvresse S, Bagot M, Wolkenstein P, Roujeau JC, Chosidow O, Valeyrie-Allanore L, (2015) Therapeutic management of DRESS: a retrospective study of 38 cases. J Am Acad Dermatol 72: 246–252 [CrossRef] [PubMed] [Google Scholar]
  • Joly P, Janela B, Tetart F, Rogez S, Picard D, D’Incan M, Descamps V, Collet E, Roujeau JC, Musette P, (2012) Poor benefit/risk balance of intravenous immunoglobulins in DRESS. Arch Dermatol 148: 543–544 [CrossRef] [PubMed] [Google Scholar]
  • Kardaun SH, Sidoroff A, Valeyrie-Allanore L, Halevy S, Davidovici BB, Mockenhaupt M, Roujeau JC, (2007) Variability in the clinical pattern of cutaneaous side-effects of drugs with systematic symptoms: does a DRESS syndrome really exist? BR J Dermatol 156(3): 609–611 [CrossRef] [PubMed] [Google Scholar]
  • Descamps V, Ranger-Rogez S, (2014) DRESS syndrome. Joint Bone Spine 81: 15–21 [CrossRef] [PubMed] [Google Scholar]
  • Tan SC, Chan GYL, (2016) Relapsing drug-induced hypersensitivity syndrome: Curr Opin Allergy Clin Immunol 16: 333–338 [CrossRef] [PubMed] [Google Scholar]
  • Thongsri T, Chularojanamontri L, Pichler WJ, (2017) Cardiac involvement in DRESS syndrome. Asian Pac J Allergy Immunol 35: 3–10 [Google Scholar]
  • Bourgeois GP, Cafardi JA, Groysman V, Hughey LC, (2012) A review of DRESS-associated myocarditis. J Am Acad Dermatol 66: e229–e236 [CrossRef] [PubMed] [Google Scholar]
  • Ichai P, Laurent-Bellue A, Saliba F, Moreau D, Besch C, Francoz C, Valeyrie-Allanore L, Bretagne SR, Boudon M, Antonini TM, Artru F, Pittau G, Roux O, Azoulay D, Levesque E, Durand F, Guettier C, Samuel D, (2017) Acute liver failure/injury related to drug reaction with eosinophilia and systemic symptoms: outcomes and prognostic factors. Transplantation 101: 1830–1837 [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.